Cabellos C, Martinez-Lacasa J, Martos A, Tubau F, Fernández A, Viladrich P F, Gudiol F
Department of Infectious Diseases, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain.
Antimicrob Agents Chemother. 1995 Sep;39(9):2158-60. doi: 10.1128/AAC.39.9.2158.
Using a rabbit model of meningitis, we sought to determine whether concomitant use of dexamethasone affects the penetration and efficacy of ceftriaxone or vancomycin in cerebrospinal fluid. Rabbits were inoculated with a penicillin-sensitive strain of Streptococcus pneumoniae and treated with ceftriaxone or vancomycin with or without dexamethasone. In the ceftriaxone-treated groups, no statistically significant differences were seen between the group treated with dexamethasone and that without dexamethasone; however, in the vancomycin-treated groups we found statistically significant lower cerebrospinal fluid vancomycin levels at 2 h in the dexamethasone-treated rabbits and differences in bacterial killing.
我们使用兔脑膜炎模型,旨在确定地塞米松的联合使用是否会影响头孢曲松或万古霉素在脑脊液中的渗透及疗效。给兔子接种对青霉素敏感的肺炎链球菌菌株,并用头孢曲松或万古霉素进行治疗,同时使用或不使用地塞米松。在头孢曲松治疗组中,使用地塞米松的组与未使用地塞米松的组之间未观察到统计学上的显著差异;然而,在万古霉素治疗组中,我们发现地塞米松治疗的兔子在2小时时脑脊液中万古霉素水平在统计学上显著较低,且在细菌杀灭方面存在差异。